SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
about
Matricellular proteins: a sticky affair with cancersNanoparticle-mediated drug delivery for treating melanomaTumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancerTP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expressionLASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer.Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisAnti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.Snail family regulation and epithelial mesenchymal transitions in breast cancer progressionThe epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasionTargeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro.SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGFTargeting tumor cell motility to prevent metastasis.Anti-cancer role of SPARC, an inhibitor of adipogenesisStem cell conditioned culture media attenuated albumin-induced epithelial-mesenchymal transition in renal tubular cells.Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.SPARC Controls Melanoma Cell Plasticity through Rac1.The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatmentAurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition.Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells.Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis.Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.Melanoma invasion - current knowledge and future directions.MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinomaDifferential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread.FKBP51 increases the tumour-promoter potential of TGF-beta.A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.SPARC: a matricellular regulator of tumorigenesis.The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.Role of SPARC in bone remodeling and cancer-related bone metastasis.Krüppel-like factors in cancer progression: three fingers on the steering wheel.Non-cell autonomous or secretory tumor suppression.Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.
P2860
Q21296660-E33D2BEB-7199-4963-9C98-C83B1F9E2CEFQ26798379-3836FC4C-14D2-4B24-9196-3B61CB01B31AQ28483867-CCB2116A-9954-43A1-8C0D-534E39EECB7FQ28510298-98474FF7-4BE0-4742-958D-E6776DF91757Q30009171-F8AF8602-14B3-4F29-A8DB-25E6AF673894Q30428429-7C48A138-FBCE-4BD5-92C8-3CC4547FE69FQ30665898-4E52AD2B-97D1-4008-99DF-6955D7EEEF49Q31083068-C7030531-A168-4D31-BCFA-F73AFAAEED6EQ33745941-D6CB1AA0-0070-4C9F-98E0-1B88CB41E69DQ33955200-6D9110E9-4E56-42F1-B9AC-62E72B347A53Q33987695-2BB9F5DC-03C4-4DE6-B7DC-25415D260543Q34095480-5AC3CEBA-7001-4C5F-AAE7-057F52DADE8FQ34387472-A08D8C53-2720-40F0-BD3E-504823803DE1Q34439076-2B72F738-EDAD-4033-B795-A15DC58A49C9Q34919118-AF3C14FE-4566-40B8-9765-88777B13DA5DQ34979996-3130FA9B-2793-4F0E-8713-9CD548752A07Q35095152-48C4589C-BB8F-45FC-98FC-4525E5E20BA7Q35116107-674FE9DA-A4D2-4713-9393-9804313BD18BQ35462023-3285E65C-28BC-4825-A8E8-58A73C4FB0BEQ35655790-5BB6FD71-D2EF-4555-996B-3B316B655CFAQ35738973-5FC83ABC-9AC2-401E-B7F6-8E4CC8C431EAQ35893442-DC133D54-1734-4EDD-BE6A-C70DE42C9C9CQ36215925-E796FB70-33B6-43D5-865A-FB8F36ECF884Q36365503-4A68D9D8-E496-485B-8B79-1CBFAD348789Q36388852-D8BFFD59-1811-4218-9B54-E22927C44481Q36663581-A372C471-2A70-4986-97A1-69A6866E7DDDQ36780416-2AED6E64-54C7-4206-8011-A91FC0FD87ABQ36828214-C1AC15A2-91D0-49EC-809F-B274126182D0Q36941240-C4CC7A15-035F-446F-B59B-8F1C70B209EDQ37429867-5A47B8CB-2DD0-4718-9BA8-003CB9A65BFDQ37531822-1DFEA1F0-885A-4FDC-A512-AF6CABBE0F09Q37573669-293D1BC5-7FA7-4B1E-8F31-ADDE46A37EDCQ37610020-6BDD38AB-11EF-4636-A447-F4BF98232DF8Q37933095-AC4894D4-7CB7-4CE2-929E-FEE81A370AF0Q38137862-4F270064-A7F6-4A68-86F7-D411B8266563Q38178811-72122C3B-54B6-4680-B96D-75475BE31168Q38206143-7CAE7223-455A-4292-9C24-B892EA500E7AQ38378532-7529EB1D-DC3E-48D3-9448-4D3B98C5F76CQ38880787-394FC769-B170-43C2-A2E3-B04FE6A9FC36Q38985417-D381E96F-54A6-42DF-BF27-A18060756F4B
P2860
SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
SPARC represses E-cadherin and ...... n during melanoma development.
@en
type
label
SPARC represses E-cadherin and ...... n during melanoma development.
@en
prefLabel
SPARC represses E-cadherin and ...... n during melanoma development.
@en
P2093
P50
P1433
P1476
SPARC represses E-cadherin and ...... n during melanoma development.
@en
P2093
Amparo Cano
Antonio Garcia de Herreros
Carine Chavey
Edith Aberdam
Emilie Sabatié
Olivier Bailet
Patricia Abbe
P304
P356
10.1158/0008-5472.CAN-05-3189
P407
P577
2006-08-01T00:00:00Z